Page last updated: 2024-08-22

pn 401 and uracil

pn 401 has been researched along with uracil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, IK; Kimura, T; Tateoka, Y; Watanabe, K; Yamamoto, I1
Ashour, OM; el Kouni, MH; Goudgaon, NM; Naguib, FN; Schinazi, RF1
Aglietta, M; Bonzano, A; Cagnazzo, C; Depetris, I; Filippi, R; Leone, F; Marino, D1
Robert, J1

Reviews

1 review(s) available for pn 401 and uracil

ArticleYear
Fluoropyrimidine-induced cardiotoxicity.
    Critical reviews in oncology/hematology, 2018, Volume: 124

    Topics: Acetates; Capecitabine; Cardiotoxicity; Cardiovascular Diseases; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyrimidines; Pyrrolidines; Quinazolines; Thiophenes; Thymine; Trifluridine; Uracil; Uridine

2018

Other Studies

3 other study(ies) available for pn 401 and uracil

ArticleYear
N-substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:12

    Topics: Animals; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Male; Mice; Phenobarbital; Sleep; Structure-Activity Relationship; Uridine

1987
Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:3

    Topics: Acetates; Animals; Biological Availability; Drug Synergism; Enzyme Inhibitors; Female; Mice; Organoselenium Compounds; Prodrugs; Uracil; Uridine; Uridine Phosphorylase

2000
[5-FU: At last!]
    Bulletin du cancer, 2019, Volume: 106, Issue:3

    Topics: Acetates; Antidotes; Antimetabolites, Antineoplastic; Dihydropyrimidine Dehydrogenase Deficiency; Fluorouracil; Humans; Neoplasms; Practice Guidelines as Topic; Pyrimidines; Uracil; Uridine

2019